Literature DB >> 9150175

Noncomplementation of radiation-induced chromosome aberrations in ataxia-telangiectasia/ataxia-telangiectasia-variant heterodikaryons.

M Stumm, K Sperling, R D Wegner.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9150175      PMCID： PMC1712422     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN： 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  33 in total

Review 1.  Ataxia-telangiectasia: closer to unraveling the mystery.

Authors:  Y Shiloh
Journal:  Eur J Hum Genet       Date:  1995       Impact factor: 4.246

2.  Digenic retinitis pigmentosa due to mutations at the unlinked peripherin/RDS and ROM1 loci.

Authors:  K Kajiwara; E L Berson; T P Dryja
Journal:  Science       Date:  1994-06-10       Impact factor: 47.728

3.  Complementation analysis in ataxia telangiectasia: fibroblast-lymphoblastoid cell heterokaryon assay by radiation-induced chromosome aberrations.

Authors:  P Chen; C Kidson
Journal:  Cytogenet Cell Genet       Date:  1993

4.  Expression cloning of multiple human cDNAs that complement the phenotypic defects of ataxia-telangiectasia group D fibroblasts.

Authors:  M S Meyn; J M Lu-Kuo; L B Herzing
Journal:  Am J Hum Genet       Date:  1993-12       Impact factor: 11.025

Review 5.  Nucleotide excision repair. II: From yeast to mammals.

Authors:  J H Hoeijmakers
Journal:  Trends Genet       Date:  1993-06       Impact factor: 11.639

6.  Studies on phenotypic complementation of ataxia-telangiectasia cells by chromosome transfer.

Authors:  W Jongmans; G W Verhaegh; N G Jaspers; M Oshimura; E J Stanbridge; P H Lohman; M Z Zdzienicka
Journal:  Am J Hum Genet       Date:  1995-02       Impact factor: 11.025

7.  Classification of Fanconi anemia patients by complementation analysis: evidence for a fifth genetic subtype.

Authors:  H Joenje; J R Lo ten Foe; A B Oostra; C G van Berkel; M A Rooimans; T Schroeder-Kurth; R D Wegner; J J Gille; M Buchwald; F Arwert
Journal:  Blood       Date:  1995-09-15       Impact factor: 22.113

8.  A single ataxia telangiectasia gene with a product similar to PI-3 kinase.

Authors:  K Savitsky; A Bar-Shira; S Gilad; G Rotman; Y Ziv; L Vanagaite; D A Tagle; S Smith; T Uziel; S Sfez; M Ashkenazi; I Pecker; M Frydman; R Harnik; S R Patanjali; A Simmons; G A Clines; A Sartiel; R A Gatti; L Chessa; O Sanal; M F Lavin; N G Jaspers; A M Taylor; C F Arlett; T Miki; S M Weissman; M Lovett; F S Collins; Y Shiloh
Journal:  Science       Date:  1995-06-23       Impact factor: 47.728

9.  Correction of radiation sensitivity in ataxia telangiectasia cells by a truncated I kappa B-alpha.

Authors:  M Jung; Y Zhang; S Lee; A Dritschilo
Journal:  Science       Date:  1995-06-16       Impact factor: 47.728

10.  A gene that regulates DNA replication in response to DNA damage is located on human chromosome 4q.

Authors:  G W Verhaegh; W Jongmans; N G Jaspers; A T Natarajan; M Oshimura; P H Lohman; M Z Zdzienicka
Journal:  Am J Hum Genet       Date:  1995-11       Impact factor: 11.025
View more
  4 in total

Review 1.  The mammalian Mre11-Rad50-nbs1 protein complex: integration of functions in the cellular DNA-damage response.

Authors:  J H Petrini
Journal:  Am J Hum Genet       Date:  1999-05       Impact factor: 11.025

2.  Nijmegen breakage syndrome cells fail to induce the p53-mediated DNA damage response following exposure to ionizing radiation.

Authors:  W Jongmans; M Vuillaume; K Chrzanowska; D Smeets; K Sperling; J Hall
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

3.  Role of Nijmegen breakage syndrome protein in specific T-lymphocyte activation pathways.

Authors:  M A García-Pérez; L M Allende; A Corell; E Paz-Artal; P Varela; A López-Goyanes; F García-Martin; R Vázquez; A Sotoca; A Arnaiz-Villena
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

4.  G2-phase radiation response in lymphoblastoid cell lines from Nijmegen breakage syndrome.

Authors:  A Antoccia; A di Masi; P Maraschio; M Stumm; R Ricordy; C Tanzarella
Journal:  Cell Prolif       Date:  2002-04       Impact factor: 6.831
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.